NFKB1 and Alzheimer disease: Results obtained from western blots (Figure 8) suggested the increased expression of MAPK- NF-κB axis in model rats and decreased of them in EX (2 g/kg, 6 g/kg) treated groups, which further confirmed the involvement of inflammation pathway in Aβ1-42 -induced AD.